Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...

Protein degradation biotech EpiBiologics has brought in $107 million in a star-studded series B round headed up by Johnson & Johnson's and Google's respective venture arms. A key goal of the San ...

Tsingke Biotech's booth at the PEGS Summit attracted attention from global biopharma professionals, with many visitors engaging in discussions and companies exploring potential collaborations. This ...

BEIJING, Jan. 20, 2026 /PRNewswire/ -- Beijing Tsingke Biotech Co., Ltd., a leading biotechnology company, today announced ...

What’s new in biotech and pharma? Over the last couple of weeks, we’ve seen the unveiling of a spatial assay for visualizing functional protein–protein interactions, an energy dispersive X-ray ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th ...

More than a year and a half into Cullinan Therapeutics’ pivot from an oncology company to a hybrid autoimmune player, the biotech is parting ways with a pair of cancer programs. The move balances the ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.